Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis

Abstract Background Plasmapheresis is an important preoperative desensitization treatment for ABO-incompatible living kidney transplantation. However, in cases with plasma exchange therapy (PET), it is necessary to consider the risks of perioperative bleeding and healthcare economic costs. This stud...

Full description

Bibliographic Details
Main Authors: Takafumi Yagisawa, Taichi Kanzawa, Yuya Fujiwara, Taro Banno, Ayaka Saito, Rikako Oki, Kohei Unagami, Toshihito Hirai, Kazuya Omoto, Norio Hanafusa, Hideki Ishida, Toshio Takagi
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Renal Replacement Therapy
Subjects:
Online Access:https://doi.org/10.1186/s41100-024-00544-0
_version_ 1797199197823303680
author Takafumi Yagisawa
Taichi Kanzawa
Yuya Fujiwara
Taro Banno
Ayaka Saito
Rikako Oki
Kohei Unagami
Toshihito Hirai
Kazuya Omoto
Norio Hanafusa
Hideki Ishida
Toshio Takagi
author_facet Takafumi Yagisawa
Taichi Kanzawa
Yuya Fujiwara
Taro Banno
Ayaka Saito
Rikako Oki
Kohei Unagami
Toshihito Hirai
Kazuya Omoto
Norio Hanafusa
Hideki Ishida
Toshio Takagi
author_sort Takafumi Yagisawa
collection DOAJ
description Abstract Background Plasmapheresis is an important preoperative desensitization treatment for ABO-incompatible living kidney transplantation. However, in cases with plasma exchange therapy (PET), it is necessary to consider the risks of perioperative bleeding and healthcare economic costs. This study investigated the association between intraoperative blood loss and the frequency of preoperative double-filtration plasmapheresis (DFPP) and explored the correlation between DFPP frequency and coagulation factors. Furthermore, the study examined the incidence of perioperative bleeding complications. Methods We enrolled 294 patients (205 men and 89 women) who underwent living kidney transplantation at our institution between January 2020 and March 2023, without PET or with only DFPP performed as PET. A single dose of rituximab (200 mg) was administered to ABO-incompatible living kidney transplant patients within 7 days before transplantation. In these patients, PET was performed until anti-blood group IgG and IgM antibody titers were reduced to 32 times or less. Results The intraoperative blood loss increased in accordance with the DFPP sessions. The amount of bleeding significantly increased when DFPP was performed ≥ 2 sessions. Considering this, we initiated serum fibrinogen level measurements from the middle of the study and observed that serum fibrinogen levels decreased in correlation with the number of DFPP sessions. Fibrinogen levels dropped to critical levels (< 100 mg/dL) after three sessions of DFPP. Within the entire cohort, four patients (1.4%) underwent post-transplantation hematoma removal surgery, and among them, three had received DFPP before transplantation. Conclusions The number of DFPP procedures was associated with the amount of bleeding and serum fibrinogen levels during living kidney transplantation.
first_indexed 2024-04-24T07:11:56Z
format Article
id doaj.art-788ec34250ae4777827380697e8f95e2
institution Directory Open Access Journal
issn 2059-1381
language English
last_indexed 2024-04-24T07:11:56Z
publishDate 2024-04-01
publisher BMC
record_format Article
series Renal Replacement Therapy
spelling doaj.art-788ec34250ae4777827380697e8f95e22024-04-21T11:30:57ZengBMCRenal Replacement Therapy2059-13812024-04-011011610.1186/s41100-024-00544-0Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresisTakafumi Yagisawa0Taichi Kanzawa1Yuya Fujiwara2Taro Banno3Ayaka Saito4Rikako Oki5Kohei Unagami6Toshihito Hirai7Kazuya Omoto8Norio Hanafusa9Hideki Ishida10Toshio Takagi11Department of Urology, Tokyo Women’s Medical UniversityDepartment of Urology, Tokyo Women’s Medical UniversityDepartment of Urology, Tokyo Women’s Medical UniversityDepartment of Urology, Tokyo Women’s Medical UniversityDepartment of Organ Transplant Medicine, Tokyo Women’s Medical UniversityDepartment of Organ Transplant Medicine, Tokyo Women’s Medical UniversityDepartment of Organ Transplant Medicine, Tokyo Women’s Medical UniversityDepartment of Urology, Tokyo Women’s Medical UniversityDepartment of Urology, Tokyo Women’s Medical UniversityDepartment of Blood Purification, Tokyo Women’s Medical UniversityDepartment of Urology, Tokyo Women’s Medical UniversityDepartment of Urology, Tokyo Women’s Medical UniversityAbstract Background Plasmapheresis is an important preoperative desensitization treatment for ABO-incompatible living kidney transplantation. However, in cases with plasma exchange therapy (PET), it is necessary to consider the risks of perioperative bleeding and healthcare economic costs. This study investigated the association between intraoperative blood loss and the frequency of preoperative double-filtration plasmapheresis (DFPP) and explored the correlation between DFPP frequency and coagulation factors. Furthermore, the study examined the incidence of perioperative bleeding complications. Methods We enrolled 294 patients (205 men and 89 women) who underwent living kidney transplantation at our institution between January 2020 and March 2023, without PET or with only DFPP performed as PET. A single dose of rituximab (200 mg) was administered to ABO-incompatible living kidney transplant patients within 7 days before transplantation. In these patients, PET was performed until anti-blood group IgG and IgM antibody titers were reduced to 32 times or less. Results The intraoperative blood loss increased in accordance with the DFPP sessions. The amount of bleeding significantly increased when DFPP was performed ≥ 2 sessions. Considering this, we initiated serum fibrinogen level measurements from the middle of the study and observed that serum fibrinogen levels decreased in correlation with the number of DFPP sessions. Fibrinogen levels dropped to critical levels (< 100 mg/dL) after three sessions of DFPP. Within the entire cohort, four patients (1.4%) underwent post-transplantation hematoma removal surgery, and among them, three had received DFPP before transplantation. Conclusions The number of DFPP procedures was associated with the amount of bleeding and serum fibrinogen levels during living kidney transplantation.https://doi.org/10.1186/s41100-024-00544-0ABO incompatibleDouble-filtration plasmapheresisFibrinogenKidney transplantation
spellingShingle Takafumi Yagisawa
Taichi Kanzawa
Yuya Fujiwara
Taro Banno
Ayaka Saito
Rikako Oki
Kohei Unagami
Toshihito Hirai
Kazuya Omoto
Norio Hanafusa
Hideki Ishida
Toshio Takagi
Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis
Renal Replacement Therapy
ABO incompatible
Double-filtration plasmapheresis
Fibrinogen
Kidney transplantation
title Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis
title_full Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis
title_fullStr Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis
title_full_unstemmed Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis
title_short Comparison of estimated blood loss during living kidney transplantation according to the number of double-filtration plasmapheresis
title_sort comparison of estimated blood loss during living kidney transplantation according to the number of double filtration plasmapheresis
topic ABO incompatible
Double-filtration plasmapheresis
Fibrinogen
Kidney transplantation
url https://doi.org/10.1186/s41100-024-00544-0
work_keys_str_mv AT takafumiyagisawa comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT taichikanzawa comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT yuyafujiwara comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT tarobanno comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT ayakasaito comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT rikakooki comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT koheiunagami comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT toshihitohirai comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT kazuyaomoto comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT noriohanafusa comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT hidekiishida comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis
AT toshiotakagi comparisonofestimatedbloodlossduringlivingkidneytransplantationaccordingtothenumberofdoublefiltrationplasmapheresis